BeOne Medicines (ONC) director Charles Sawyers reports initial ADS and share holdings
Rhea-AI Filing Summary
BeOne Medicines Ltd. director Charles Lazelle Sawyers filed an initial Form 3 reporting his ownership in the company. He directly holds 1,946 American Depositary Shares and 4 ordinary shares as of June 11, 2026. Each American Depositary Share represents 13 ordinary shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Sawyers Charles Lazelle
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 4 shares (Direct);
American Depositary Shares — 1,946 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
American Depositary Shares held: 1,946 ADS
Ordinary shares held: 4 ordinary shares
ADS to ordinary share ratio: 1 ADS = 13 ordinary shares
3 metrics
American Depositary Shares held
1,946 ADS
Direct holdings as of June 11, 2026
Ordinary shares held
4 ordinary shares
Direct holdings as of June 11, 2026
ADS to ordinary share ratio
1 ADS = 13 ordinary shares
Stated in footnote
Key Terms
American Depositary Shares, Ordinary Shares, beneficial ownership, Form 3
4 terms
beneficial ownership financial
"This Form 3 is an initial statement of beneficial ownership."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Form 3 regulatory
"Form 3 is used to report an insider’s initial holdings."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the BeOne Medicines (ONC) Form 3 filing show for Charles Lazelle Sawyers?
The Form 3 shows that director Charles Lazelle Sawyers initially reported holding 1,946 American Depositary Shares and 4 ordinary shares of BeOne Medicines Ltd. as of June 11, 2026, reflecting his starting beneficial ownership position.
Are Charles Lazelle Sawyers’ BeOne Medicines (ONC) holdings direct or indirect?
The Form 3 indicates that all reported holdings are directly owned. Both the 1,946 American Depositary Shares and the 4 ordinary shares are classified with direct ownership, with no indirect entities or special ownership structures disclosed in the filing.